Kleo Pharmaceuticals Inc. Appoints David A. Spiegel as Chief Executive Officer
Go back to Kleo Pharmaceuticals Inc. Appoints David A. Spiegel as Chief Executive Officer| Portage Biotech, Inc. (AMEX: PTGEF) | Delayed: 37.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.50 | 52 Week High | $0.17 | |||
| Open | $36.59 | 52 Week Low | $0.08 | |||
| Day High | $37.50 | P/E | N/A | |||
| Day Low | $37.50 | EPS | $0.00 | |||
| Volume | 144,782 | |||||
